2016 Press Releases

Keyword Search
 
Current | Archive
DateTitle 
09/06/16OraSure Technologies to Present at the CL King 14th Annual Best Ideas Conference
BETHLEHEM, Pa., Sept. 06, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the CL King 14th Annual Best Ideas Conference in New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on September 13, 2016, at approximately 10:15 AM Eastern Time (7:1... 
Printer Friendly Version
08/29/16DNA Genotek’s OMNIgene®Ÿ GUT Kit is Proposed as Standardized Test for Worldwide Studies of the Human Microbiome
Human Longevity Inc. Study on OMNIgene®Ÿ GUT Recently Published in Scientific Reports BETHLEHEM, Pa., Aug. 29, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that a study conducted by Human Longevity, Inc. (HLI) and published in the Journal Scientific Reports (Nature Publishing Group) on August 25, 2016 proposes the use of the OMNIgene•GUT microbiome sample collection and stabilization device sold by OraSure’s wholly-owned subsidiary, DNA Genotek Inc., in gl... 
Printer Friendly Version
08/23/16OraSure Awarded Up to $16.6 Million to Advance Rapid Zika Tests
BETHLEHEM, Pa., Aug. 23, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it has been awarded a contract for up to $16.6 million in total funding from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response’s Biomedical Advanced Research and Development Authority (BARDA) to advance the Company’s rapid Zika tests. Th... 
Printer Friendly Version
08/03/16OraSure Announces 2016 Second Quarter Financial Results
BETHLEHEM, Pa., Aug. 03, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and six months ended June 30, 2016. Financial Highlights Consolidated net revenues for the second quarter of 2016 were $31.4 million, a 3% increase from the second quarter of 2015. Consolidated net revenues for the six months ended June 30, 2016 were $60.4 ... 
Printer Friendly Version
08/01/16OraSure Technologies to Present at the Canaccord Genuity 36th Annual Growth Conference
BETHLEHEM, Pa., Aug. 01, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity 36th Annual Growth Conference in Boston, Massachusetts.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak August 10, 2016, at approximately 9:30 AM Easte... 
Printer Friendly Version
07/13/16OraSure Technologies Earnings Conference Call Invitation
2016 Second Quarter Earnings Conference Call Wednesday, August 3, 2016, 5:00 p.m. ET BETHLEHEM, Pa., July 13, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 second quarter financial results, 2016 third quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, August 3, 2016.      August 3, 2016 Schedule       ... 
Printer Friendly Version
07/01/16OraSure Technologies and AbbVie Agree to an Early Termination of HCV Co-Promotion Agreement
Investor Conference Call Scheduled Today at 8:30 a.m. Eastern Time BETHLEHEM, Pa., July 01, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies (NASDAQ:OSUR), a market leader in point of care diagnostics, announced today that OraSure Technologies and AbbVie have mutually agreed to an early termination of their Master Program Services and Co-Promotion Agreement under which the companies have been co-promoting OraSure’s OraQuick® HCV Rapid Antibody Test in the United States. The agreement was origina... 
Printer Friendly Version
06/30/16OraSure Technologies Investor Call Invitation
Investor Conference Call July 1, 2016, 8:30 a.m. ET BETHLEHEM, Pa., June 30, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled an investor conference call and simultaneous webcast for 8:30 a.m. ET (5:30 a.m. PT) on July 1, 2016 to provide an update on the Company’s HCV business and certain other developments. July 1, 2016 Schedule 8:20 a.m. ET To participate in the conference call, dial 844-831-3030 (Domestic) or 315-625-6887 (International) and reference ... 
Printer Friendly Version
05/31/16OraSure Technologies to Present at the Jefferies 2016 Healthcare Conference
BETHLEHEM, Pa., May 31, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Jefferies 2016 Healthcare Conference in New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak June 8, 2016, at approximately 8:30 AM Eastern Time (5:30 AM Pacific Time).  Interested investors can access the live webcast of the presentation by goi... 
Printer Friendly Version
05/10/16OraSure Technologies to Hold Virtual Annual Meeting of Stockholders
BETHLEHEM, Pa., May 10, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), announced that its 2016 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) on Tuesday, May 17, 2016. In order to access the meeting, interested parties may go to www.virtualshareholdermeeting.com/OSUR2016 five (5) minutes prior to the start of the meeting to log in. Stockholders must enter the c... 
Printer Friendly Version



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet